Table 1.
Patient characteristics.
| Patient | Gender | Age (years) | Location | Size (mm) | Therapy | M-protein | FLC ratio | PET-CT | R/P to MM | Follow up (Months) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 67 | Oropharynx | 30 | Surgery | neg | neg | neg | No | 16 |
| 2 | M | 49 | Nasal | 8 | Surgery | neg | neg | neg | No | 101 |
| 3 | M | 57 | Nasal | 40 | Surgery | neg | neg | neg | No | 14 |
| 4 | M | 63 | Hypopharynx | 15 | Surgery | neg | neg | ND | No | 51 |
| 5 | M | 57 | Oropharynx | 33 | Radiotherapy | IgG/lambda 5.2 g/L | neg | neg | No | 61 |
| 6 | M | 23 | Lymph node | 25 | Surgery/ Radiotherapy | neg | neg | neg | No | 26 |
| 7 | F | 64 | Epipharynx | 20 | Surgery | neg | neg | neg | No | 93 |
| 8 | M | 83 | Nasal | 15 | Surgery | neg | neg | neg | No | 4 |
M-protein=monoclonal protein; FLC=free light chains; MM=multiple myeloma, R/P to MM=recurrence or progression to multiple myeloma.